Ovarian hyperstimulation syndrome prevention strategies: Use of gonadotropin-releasing hormone antagonists

Seminars in Reproductive Medicine

Volumn 28, Issue 6, 2010, Pages 493-499

  Griesinger, Georg ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

GnRH agonist; GnRH antagonist; OHSS prevention; Ovarian hyperstimulation syndrome; ovarian stimulation

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN ANTAGONIST;

CRYOPRESERVATION; EMBRYO TRANSFER; HUMAN; LUTEAL PHASE; OOCYTE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; PREGNANCY; PRIMARY PREVENTION; REVIEW; SECONDARY PREVENTION;

FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MODELS, BIOLOGICAL; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PRIMARY PREVENTION; SECONDARY PREVENTION; TERTIARY PREVENTION;

EID: 78649291030     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1265676     Document Type: Review

References (41)

1. Serour G I., Aboulghar M, Mansour R, Sattar M A., Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril 1998 70 (4) 638-642
2. Arya R, Shehata H A., Patel R K. et al. Internal jugular vein thrombosis after assisted conception therapy. Br J Haematol 2001 115 (1) 153-155
3. Klemetti R, Sevón T, Gissler M, Hemminki E. Complications of IVF and ovulation induction. Hum Reprod 2005 20 (12) 3293-3300
4. Mára M, Koryntová D, Rezábek K et al. Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study [in Czech]. Ceska Gynekol 2004 69 (4) 312-316
5. Brinsden P R., Wada I, Tan S L., Balen A, Jacobs H S. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995 102 (10) 767-772
6. Papanikolaou E G., Pozzobon C, Kolibianakis E M. et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 2006 85 (1) 112-120
7. Borm G, Mannaerts B The European Orgalutran Study Group. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 2000 15 (7) 1490-1498
8. European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001 16 (4) 644-651
9. Fluker M, Grifo J, Leader A et al North American Ganirelix Study Group. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001 75 (1) 38-45
10. Kolibianakis E M., Collins J, Tarlatzis B C., Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006 12 (6) 651-671
11. Al-Inany H G., Abou-Setta A M., Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 2007 14 (5) 640-649
12. Ragni G, Vegetti W, Riccaboni A, Engl B, Brigante C, Crosignani P G. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Hum Reprod 2005 20 (9) 2421-2425
13. Felberbaum R E., Reissmann T, Küpker W et al. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gynecol Reprod Biol 1995 61 (2) 151-155
14. Fauser B C., de Jong D, Olivennes F et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 2002 87 (2) 709-715
15. Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006 13 (2) 173-178
16. Babayof R, Margalioth E J., Huleihel M et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 2006 21 (5) 1260-1265
17. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008 89 (1) 84-91
18. Galindo A, Bodri D, Guillén J J., Colodrón M, Vernaeve V, Coll O. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol Endocrinol 2009 25 (1) 60-66
19. Bodri D, Guillén J J., Galindo A, Mataró D, Pujol A, Coll O. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 2009 91 (2) 365-371
20. Griesinger G, Diedrich K, Tarlatzis B C., Kolibianakis E M. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 2006 13 (5) 628-638
21. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004 81 (1) 1-5
22. Gonen Y, Balakier H, Powell W, Casper R F. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 1990 71 (4) 918-922
23. Nevo O, Eldar-Geva T, Kol S, Itskovitz-Eldor J. Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin. Fertil Steril 2003 79 (5) 1123-1128
24. Humaidan P, Bredkjaer H E., Bungum L et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005 20 (5) 1213-1220 (Pubitemid 40796107)
25. Erb T M., Vitek W, Wakim A N. Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program. Fertil Steril 2010 93 (2) 374-378
26. Galindo A, Bodri D, Guillén J J., Colodrón M, Vernaeve V, Coll O. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol Endocrinol 2009 25 (1) 60-66
27. Acevedo B, Gomez-Palomares J L., Ricciarelli E, Hernández E R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril 2006 86 (6) 1682-1687
28. Shapiro B S., Daneshmand S T., Garner F C., Aguirre M, Ross R. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles. Fertil Steril 2007 88 (1) 237-239
29. Griesinger G, Kolibianakis E M., Papanikolaou E G. et al. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril 2007 88 (3) 616-621
30. Erden H F., Akman M A., Çiray N, Bahçeci M. The results of fresh and frozen thaw embryo transfer cycles of PCOS patients in which GnRH-ant were used together with GnRHa for LH surge. Fertil Steril 2005 84 (Suppl 1) S164 (P-36)
31. Eldar-Geva T, Zylber-Haran E, Babayof R et al. Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation. Reprod Biomed Online 2007 14 (2) 148-154
32. Kolibianakis E M., Schultze-Mosgau A, Schroer A et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 2005 20 (10) 2887-2892
33. Youssef M, Griesinger G, Van Wely M, AL-Inany H, Van der Veen F. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist ART cycles. A systematic review and metaanalysis. Abstracts of the 25th Annual Meeting of ESHRE, Amsterdam, the Netherlands, 28 June1 July, 2009. Hum Reprod 2009 24 (Suppl) 1241-1530
34. Yding Andersen C, Humaidan P. Characteristics of follicular fluid from women receiving either Buserelin or hCG to induce ovulation. Hum Reprod 2005 20 (Suppl 1) 65
35. Engmann L, Siano L, Schmidt D, Nulsen J, Maier D, Benadiva C. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. Reprod Biomed Online 2006 13 (5) 639-644
36. Kol S, Solt I. GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? J Assist Reprod Genet 2008 25 (23) 63-66
37. Griesinger G, von Otte S, Schroer A et al. Elective cryopreservation of all pronuclear oocytes after GnRH-agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod 2007 22 (5) 1348-1352
38. Manzanares M A., Gómez-Palomares J L., Ricciarelli E, Hernández E R. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Fertil Steril 2010 93 (4) 1215-1219
39. Lainas T G., Sfontouris I A., Zorzovilis I Z., Petsas G K., Lainas G T., Kolibianakis E M. Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist. Reprod Biomed Online 2007 15 (4) 408-412
40. Lainas T G., Sfontouris I A., Zorzovilis I Z. et al. Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol. Reprod Biomed Online 2009 18 (1) 15-20
41. Lainas T G., Sfontouris I A., Zorzovilis I Z. et al. Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase. Reprod Biomed Online 2009 19 (6) 789-795